β₂-adrenoceptor agonists: current and future directionCAZZOLA, Mario; CALZETTA, Luigino; MATERA, Maria Gabriella et al.British journal of pharmacology. 2011, Vol 163, Num 1, pp 4-17, issn 0007-1188, 14 p.Article

The arginine-16 β₂-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterolLEE, Daniel K. C; CURRIE, Graeme P; HALL, Ian P et al.British journal of clinical pharmacology. 2004, Vol 57, Num 1, pp 68-75, issn 0306-5251, 8 p.Article

A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmaticsCURRIE, Graeme P; LEE, Daniel K. C; DEMPSEY, Owen J et al.British journal of clinical pharmacology. 2003, Vol 55, Num 6, pp 609-615, issn 0306-5251, 7 p.Article

Harnessing the Clinical Efficacy of Phosphodiesterase 4 Inhibitors in Inflammatory Lung Diseases: Dual-Selective Phosphodiesterase Inhibitors and Novel Combination TherapiesGIEMBYCZ, Mark A; NEWTON, Robert.Handbook of experimental pharmacology. 2011, Vol 204, pp 415-446, issn 0171-2004, 32 p.Article